05:02 PM EDT, 04/16/2024 (MT Newswires) -- TScan Therapeutics ( TCRX ) said late Tuesday it launched a $125 million public offering of its securities.

The offering comprises the company's voting common stock and, in lieu of such stock, pre-funded warrants to purchase the shares.

TScan said it plans to use the net proceeds for general corporate purposes.

The company's shares were up 1.1% in after-hours activity.